Daniel W. Seekins

Infectious Disease

777 Scudders Mill Rd
Plainsboro, NJ 08536

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 21 publications

The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative.

The Impact of COVID-19 and COVID-19 Vaccination on Detection, Assessment, and Management of Suspected Acute Drug-Induced Liver Injury Occurring during Clinical Trials: Consensus Recommendations from the IQ DILI Initiative.

Journal: Drug safety

Published: July 13, 2025

The Antiretroviral Pregnancy Registry: Three decades of prospective monitoring for birth defects.

The Antiretroviral Pregnancy Registry: Three decades of prospective monitoring for birth defects.

Journal: Pharmacoepidemiology and drug safety

Published: November 22, 2023

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials.

Overview of Causality Assessment for Drug-Induced Liver Injury (DILI) in Clinical Trials.

Journal: Drug safety

Published: February 01, 2021

Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis.

Consensus Guidelines: Best Practices for Detection, Assessment and Management of Suspected Acute Drug-Induced Liver Injury During Clinical Trials in Adults with Chronic Viral Hepatitis and Adults with Cirrhosis Secondary to Hepatitis B, C and Nonalcoholic Steatohepatitis.

Journal: Drug safety

Published: October 07, 2020

Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.

Consensus guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury occurring during clinical trials in adults with chronic cholestatic liver disease.

Journal: Alimentary pharmacology & therapeutics

Published: May 21, 2019

Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis.

Consensus: guidelines: best practices for detection, assessment and management of suspected acute drug-induced liver injury during clinical trials in patients with nonalcoholic steatohepatitis.

Journal: Alimentary pharmacology & therapeutics

Published: October 03, 2018

No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data.

No Evidence of an Association Between Efavirenz Exposure and Suicidality Among HIV Patients Initiating Antiretroviral Therapy in a Retrospective Cohort Study of Real World Data.

Journal: Medicine

Published: January 29, 2016

Efavirenz Capsule Sprinkle and Liquid Formulations With Didanosine and Emtricitabine in HIV-1-infected Infants and Children 3 Months to 6 Years of Age: Study AI266-922.

Efavirenz Capsule Sprinkle and Liquid Formulations With Didanosine and Emtricitabine in HIV-1-infected Infants and Children 3 Months to 6 Years of Age: Study AI266-922.

Journal: The Pediatric infectious disease journal

Published: September 18, 2015

The Impact of State AIDS Drug Assistance Policies on Clinical and Economic Outcomes of People With HIV.

The Impact of State AIDS Drug Assistance Policies on Clinical and Economic Outcomes of People With HIV.

Journal: Medical care research and review : MCRR

Published: November 26, 2014

Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1.

Summaries for patients. Nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1.

Journal: Annals of internal medicine

Published: October 07, 2014

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

Efficacy and tolerability of 3 nonnucleoside reverse transcriptase inhibitor-sparing antiretroviral regimens for treatment-naive volunteers infected with HIV-1: a randomized, controlled equivalence trial.

Journal: Annals of internal medicine

Published: October 07, 2014

Comparative value of four measures of retention in expert care in predicting clinical outcomes and health care utilization in HIV patients.

Comparative value of four measures of retention in expert care in predicting clinical outcomes and health care utilization in HIV patients.

Journal: PloS one

Published: April 16, 2014

Showing 1-12 of 21

Last Updated: 09/26/2026